Gilder Gagnon Howe & CO LLC Delcath Systems, Inc. Transaction History
Gilder Gagnon Howe & CO LLC
- $8.56 Billion
- Q4 2024
A detailed history of Gilder Gagnon Howe & CO LLC transactions in Delcath Systems, Inc. stock. As of the latest transaction made, Gilder Gagnon Howe & CO LLC holds 612,235 shares of DCTH stock, worth $9.75 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
612,235Holding current value
$9.75 Million% of portfolio
0.08%Shares
1 transactions
Others Institutions Holding DCTH
# of Institutions
88Shares Held
10.1MCall Options Held
188KPut Options Held
23.1K-
Vivo Capital, LLC Palo Alto, CA1.71MShares$27.2 Million3.93% of portfolio
-
Aigh Capital Management LLC Baltimore, MD1.39MShares$22.1 Million6.61% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.22MShares$19.5 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT801KShares$12.8 Million0.66% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA419KShares$6.66 Million0.0% of portfolio
About DELCATH SYSTEMS, INC.
- Ticker DCTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 8,597,680
- Market Cap $137M
- Description
- Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...